Robert J Soiffer Selected Research

Drug Therapy (Chemotherapy)

1/2021	Randomized Study of enterade® to Reduce Diarrhea in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation.
12/2020	Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant.
10/2018	Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program.
1/2018	A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.
9/2017	Oral health status and risk of bacteremia following allogeneic hematopoietic cell transplantation.
6/2017	Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
1/2016	Allogeneic transplantation is not superior to chemotherapy in most patients over 40 years of age with Philadelphia-negative acute lymphoblastic leukemia in first remission.
9/2013	Impact of physician assistants on the outcomes of patients with acute myelogenous leukemia receiving chemotherapy in an academic medical center.
2/2007	High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials.
10/2006	Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert J Soiffer Research Topics

Disease

67	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 10/2002
44	Neoplasms (Cancer) 02/2024 - 05/2002
38	Bronchiolitis Obliterans Syndrome 01/2023 - 04/2004
33	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 09/2003
32	Leukemia 02/2024 - 10/2002
26	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 09/2003
18	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2024 - 09/2003
11	Infections 01/2023 - 07/2002
10	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2014 - 05/2002
9	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 11/2022 - 07/2010
9	Lymphoma (Lymphomas) 01/2018 - 04/2008
8	Multiple Myeloma 11/2023 - 06/2002
6	Melanoma (Melanoma, Malignant) 11/2005 - 05/2002
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 12/2005
4	Acute Kidney Injury (Acute Renal Failure) 11/2023 - 01/2019
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2019
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2019 - 01/2016
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2017 - 04/2008
3	Myeloid Leukemia (Leukemia, Myelocytic) 02/2024 - 02/2010
3	Opportunistic Infections (Opportunistic Infection) 11/2023 - 01/2018
3	Cytokine Release Syndrome 01/2023 - 01/2021
3	Pathologic Complete Response 09/2012 - 09/2011
3	Iron Overload 06/2012 - 05/2007
2	Cytopenia 05/2024 - 01/2021
2	Critical Illness (Critically Ill) 11/2023 - 01/2019
2	COVID-19 01/2023 - 01/2021
2	Bronchiolitis Obliterans 12/2022 - 02/2013
2	Injection Site Reaction 12/2022 - 11/2017
2	Hematuria 11/2022 - 12/2020
2	Hypotension (Low Blood Pressure) 11/2022 - 03/2016
2	Diarrhea 01/2021 - 09/2011
2	Carcinoma (Carcinomatosis) 01/2018 - 04/2003
2	Inflammation (Inflammations) 01/2018 - 01/2015
2	Hodgkin Disease (Hodgkin's Disease) 05/2017 - 02/2009
2	Venous Thromboembolism 01/2017 - 02/2013
2	Pneumonia (Pneumonitis) 06/2014 - 05/2004
2	Exanthema (Rash) 02/2014 - 03/2011
2	Colitis 08/2013 - 09/2011

Drug/Important Bio-Agent (IBA)

20	Tacrolimus (Prograf)FDA LinkGeneric 01/2024 - 09/2003
17	AntigensIBA 01/2023 - 05/2002
14	Sirolimus (Rapamycin)FDA Link 01/2020 - 09/2003
13	Methotrexate (Mexate)FDA LinkGeneric 01/2024 - 09/2003
13	Interleukin-2 (IL2)IBA 11/2022 - 09/2006
12	VaccinesIBA 01/2023 - 05/2002
10	AntibodiesIBA 12/2017 - 05/2002
9	SteroidsIBA 01/2023 - 08/2004
8	Busulfan (Busulfex)FDA Link 02/2024 - 04/2008
7	fludarabineIBA 02/2024 - 04/2008
7	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2022 - 05/2002
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 09/2003
6	Monoclonal AntibodiesIBA 01/2023 - 10/2002
6	defibrotideIBA 01/2020 - 07/2010
6	Minor Histocompatibility AntigensIBA 03/2010 - 01/2003
5	Proteins (Proteins, Gene)FDA Link 02/2024 - 03/2003
5	CytokinesIBA 01/2022 - 11/2002
5	Bortezomib (Velcade)FDA Link 01/2018 - 10/2009
5	Complementary DNA (cDNA)IBA 03/2015 - 05/2002
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 11/2012
4	Immune Checkpoint InhibitorsIBA 01/2023 - 07/2016
4	IpilimumabIBA 01/2023 - 02/2009
4	trans-crotonin (CTN)IBA 01/2022 - 05/2012
4	Calcineurin InhibitorsIBA 01/2022 - 05/2004
4	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2021 - 09/2004
4	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 06/2013
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 10/2016
3	Thomsen-Friedenreich antibodiesIBA 11/2018 - 06/2011
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 06/2012
3	Immunoglobulins (Immunoglobulin)IBA 06/2014 - 02/2010
3	B-Cell Activating FactorIBA 05/2014 - 10/2007
3	Rituximab (Mabthera)FDA Link 06/2013 - 04/2010
3	Peptides (Polypeptides)IBA 03/2012 - 03/2003
2	venetoclaxIBA 01/2024 - 12/2021
2	Abatacept (Orencia)FDA Link 01/2023 - 01/2018
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 11/2022
2	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2023
2	Alemtuzumab (Campath)FDA Link 01/2023 - 05/2013
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
2	Natalizumab (Tysabri)FDA Link 05/2021 - 01/2021
2	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 10/2016
2	Phosphotransferases (Kinase)IBA 01/2020 - 12/2008
2	GlobulinsIBA 11/2018 - 12/2017
2	IronIBA 06/2012 - 06/2011
2	Ferritins (Ferritin)IBA 06/2012 - 06/2011
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2009 - 12/2003
2	AutoantibodiesIBA 03/2007 - 10/2002

Therapy/Procedure

75	Hematopoietic Stem Cell Transplantation 01/2024 - 07/2002
47	Therapeutics 02/2024 - 06/2002
40	Transplantation 11/2023 - 06/2002
34	Cell Transplantation 05/2024 - 02/2003
30	Stem Cell Transplantation 02/2024 - 12/2003
11	Homologous Transplantation 01/2023 - 08/2004
11	Drug Therapy (Chemotherapy) 01/2021 - 06/2002
6	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 04/2016 - 05/2004
4	Immunotherapy 01/2023 - 10/2002
3	Aftercare (After-Treatment) 07/2023 - 02/2010
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 06/2005 - 07/2002
2	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2021 - 01/2021
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2020 - 01/2019
2	Salvage Therapy 12/2019 - 04/2010
2	Autologous Transplantation 05/2017 - 02/2007